文献速递瓣膜外科先天性心脏病外科

Melody瓣与机械瓣二尖瓣置换在幼儿中的倾向性匹配分析

Melody vs Mechanical Mitral Valve Replacement in Young Children: A Single-Center Propensity Matched Analysis.
PubMed 文献 · Ann Thorac Surg · 2025-08-25

该单中心回顾性研究纳入2005至2023年36例<2岁接受Melody或机械二尖瓣置换患儿,倾向性匹配后每组12例。匹配组基线相似,中位随访2.3年。5年无移植生存率两组无差异(Melody 66.7% vs 机械瓣 66.0%,P=.96),2年再手术累积发生率亦无差异(32.2% vs 30.3%,P=.3)。结论认为Melody瓣可作机械瓣的替代选择,避免全身抗凝。

要点

  • Melody与机械二尖瓣置换在幼儿中5年无移植生存率相当。
  • 两组2年再手术累积发生率无显著差异。
  • 机械瓣组出院起搏器需求36.4%,Melody组0%(P=.08)。

核心结论

  • Melody二尖瓣置换可作为机械瓣的合适替代,中期发病率与死亡率相当,且避免全身抗凝。

研究设计与样本

  • 单中心回顾性研究,2005至2023年纳入36例年龄<2岁接受Melody或机械二尖瓣置换的患儿。
  • 采用倾向性评分匹配后每组12例,中位随访2.3年(IQR 0.4-6.7)。

主要发现

  • 匹配组中位年龄5.2个月(IQR 3.5-10.2),中位体重6.5 kg(IQR 4.9-7.6)。
  • 机械瓣组出院起搏器需求4例(36.4%),Melody组0例(P=.08)。
  • 早期再手术两组均为16.7%(P=1.00)。
  • 5年无移植生存率Melody 66.7%、机械瓣66.0%(P=.96)。
  • 2年再手术累积发生率Melody 32.2%、机械瓣30.3%(P=.3)。

临床怎么用

  • 对于<2岁需二尖瓣置换的患儿,Melody瓣可作为机械瓣的替代选择,以避免全身抗凝。

局限性

  • 单中心回顾性设计,样本量小(匹配后每组12例),随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To examine outcomes of Melody (Medtronic) vs mechanical mitral valve replacement (MVR) in young children. METHODS: We retrospectively reviewed 36 patients aged <2 years who underwent Melody or mechanical MVR between 2005 and 2023. Propensity score matching was performed to account for baseline differences, yielding 2 groups of 12 patients. Transplant-free survival and cumulative incidence of surgical reintervention were compared. Median follow-up time was 2.3 (interquartile range [IQR], 0.4-6.7) years. RESULTS: Matched groups were similar across baseline parameters. Median age and weight were 5.2 (IQR, 3.5-10.2) months and 6.5 (IQR, 4.9-7.6) kg. In the mechanical group, 4 (36.4%) patients had a pacemaker requirement at discharge, compared with 0 Melody patients (P = .08). Early surgical reinterventions occurred in both groups (16.7% vs 16.7%, P = 1.00). There were 2 early mortalities: 1 in a Melody patient salvaged from mechanical support and 1 in a patient who developed left atrioventricular groove hematoma due to Melody overdilation. There were no differences in transplant-free survival at 5 years (Melody: 66.7%; Mechanical: 66.0%; P = .96) or cumulative incidence of surgical reintervention at 2 years (Melody: 32.2%; Mechanical: 30.3%; P = .3). CONCLUSIONS: Melody MVR offers a suitable alternative to mechanical MVR, with comparable mid-term morbidity and mortality, while avoiding systemic anticoagulation.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Moroi MK, Vinogradsky AV, Feng I, et al. Melody vs Mechanical Mitral Valve Replacement in Young Children: A Single-Center Propensity Matched Analysis. Ann Thorac Surg. 2025. PMID: 40865785. doi:10.1016/j.athoracsur.2025.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。